CKD USA was incorporated in 1985 as a wholly-owned subsidiary of CKD Corporation, Komaki, Japan, with the primary responsibility of providing sales and technical support for the Americas.
广告Reduce Risk Of End-Stage KidneyDisease In Your CKD in T2D Patients With A Treatment. Reduce The Risk Of Sustained eGFR Decline In CKD in T2D Patients With A Once-Daily Pill.
Types: Downloadable Resources, Case Study Videos, Clinical Trial Data
English
保存
分享
更多